By Chris Bailey | Monday 3 September 2018
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
I think Dechra Pharmaceuticals (DPH) was the first initial public offering I looked at as a junior analyst on a hedge fund many years ago. It was a bit on the small side for us if I recall, but the essential business of specialist veterinary pharmaceutical products seemed quite sensible to me. After all we love animals almost more than anything else, right?